Withdrawal of Voxelotor: Implications for Clinical Practice in Sickl…

Akshat Jain

PKD: Diagnosis, Treatment and Monitoring for Complications

Stanford Medicine

M. Chien

Mitapivat in PKD: Results of the ACTIVATE Trial and Updated Treatmen…

Stefan Eber

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

Anemia and Thrombocytopenia Basics

UNC Lineberger Comprehensive Cancer Center

N. Vogler

The Role of Complement in Disease: Focus on PNH, aHUS, CAPS, and CAD

Ilene Weitz

Diagnosis and Testing Considerations for Cold Agglutinin Disease

Julia Cunningham

PKD Epidemiology, Diagnosis, and Management

Stefan Eber

CAD: The Basics and Development

Kelly Davidson

Putting the Freeze on Cold Agglutinin Disease

i3 Health

C. Broome

The Evolving Science of Pyruvate Kinase Activation

Joan-Lluis Vives Corrons

Advances in Hemolytic Anemias: Enzymopathies, Membrane Defects, Auto…

Scripps Health

I. Weitz

The Impact of Mitapivat Treatment on Work/School Activity for Adult …

Kevin Kuo

Preventing Relapse in iTTP

Senthil Sukumar

Mitapivat in PKD: Meta Analysis of Clinical Trials and Real-World Da…

Hazem Mohammed

Sutimlimab in Cold Agglutinin Disease

Kelly Davidson

Trends and Disparities in Next-Generation Sequencing for Metastatic …

Umang Swami

Mitapivat for Thalassemia: Results From the Ph3 ENERGIZE-T Study

Stefan Eber

A Multidisciplinary Team Approach to TTP

Penn Medicine Abramson Cancer Center

D. Siegel

Molecular vs. Multidisciplinary Tumour Boards in Skin Cancers

Alberto Cunquero